More News
Want to Read Locked Articles?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Children’s Hospital Los Angeles Celebrates 100th Luxturna Procedure
Author: Jennie Crabbe
Children’s Hospital Los Angeles (CHLA) marked a milestone recently, completing its 100th procedure with the retinal gene therapy Luxturna for Leber congenital amaurosis (LCA)—the most of any center in the US. Children with LCA experience a rapid decline in their vision as they grow, starting with poor vision in dim light and night blindness. Ultimately, patients lose all of their sight by middle age. Luxturna gained US FDA approval in December 2017. The therapy replaces a defective gene calle...
